Will Surging 2025 Trading Volumes Reshape TMX Group's (TSX:X) Earnings Momentum Narrative?

• TMX Group recently reported its November 2025 trading statistics, showing year-to-date increases in volume, value, and transactions across the Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, and Montréal Exchange, while also confirming past and upcoming holiday closures and shortened hours for its Canadian marketplaces.
• The strong rise in trading activity, particularly the very large year-on-year increases in total volume and value, highlights how higher market participation can directly lift TMX Group’s underlying operational metrics.
• We’ll now examine how this surge in year-to-date trading activity might influence TMX Group’s existing investment narrative around earnings momentum.

The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

TMX Group Investment Narrative Recap

To own TMX Group, you generally need to believe that higher trading activity and healthy listing volumes will continue to support its earnings profile, even as competition and alternative capital-raising channels evolve. The November 2025 spike in volumes and value traded is positive for near term revenue momentum, but it does not materially change the key risk that TMX’s reliance on traditional public markets could be challenged by private and alternative funding options.

Among recent announcements, TMX’s Q3 2025 results stand out, with sales of CA$418.6 million and net income of CA$120.5 million, reinforcing how increased trading activity can feed into top line growth and earnings momentum. When set alongside the November trading statistics, these results help frame the core near term catalyst for the stock as the ability to translate higher market participation into consistent profit growth without eroding margins.

Yet investors should also be aware that growing competition from global exchanges could...

Read the full narrative on TMX Group (it's free!)

TMX Group's narrative projects CA$2.0 billion revenue and CA$692.5 million earnings by 2028. This requires 7.3% yearly revenue growth and about a CA$270 million earnings increase from CA$422.0 million today.

Uncover how TMX Group's forecasts yield a CA$62.50 fair value, a 22% upside to its current price.

Exploring Other Perspectives

Five Simply Wall St Community fair value estimates for TMX Group span roughly CA$36.72 to CA$62.50, underlining how far apart retail views can be. You should weigh those opinions against the recent surge in trading volumes, which may support earnings but does not remove longer term threats from alternative funding markets and competing exchanges.

Explore 5 other fair value estimates on TMX Group - why the stock might be worth 28% less than the current price!

Build Your Own TMX Group Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your TMX Group research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free TMX Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate TMX Group's overall financial health at a glance.

Interested In Other Possibilities?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
• These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com